يعرض 1 - 1 نتائج من 1 نتيجة بحث عن '"Д. Кркошка ; Братиславский университет им. Я. Коменского"', وقت الاستعلام: 0.36s تنقيح النتائج
  1. 1
    Electronic Resource

    Additional Titles: Различные исходы энцефалита, вызванного Herpes Simplex Virus (клинические и ЭЭГ наблюдения)

    المصدر: General Reanimatology; Том 16, № 2 (2020); 41-51; Общая реаниматология; Том 16, № 2 (2020); 41-51; 2411-7110; 1813-9779; 10.15360/1813-9779-2020-2

    URL: https://www.reanimatology.com/rmt/article/view/1883/1392
    https://www.reanimatology.com/rmt/article/view/1883/1392
    Mayer V., Drobný M., Mittrová E. Pomalé vírusové neuroinfekcie. Edition, Osveta, Martin, 1983, 407p.
    Xu F., Sternburg M., Kottiri B., McQuilan G., Lee F., Nahmias A. Berman S., Markowitz L. Trends in Herpes Simplex Virus Type1 and Type 2 Seroprevalence in the United States. AMA. 2006; 8. 296 (8): 964–973. PMID: 16926356 DOI: 10.1001/jama.296.8.964
    Whitley R.J. Herpes simplex encephalitis: adolescents and adults. Antiviral Res. 2006; 71 (2–3): 141–148. PMID: 16675036 DOI: 10.1016/j.antiviral.2006.04.002
    Whitley R.J., Gnann J.W. Viral encephalitis: familiar infections and emerging pathogens. Lancet. 2002; 359 (9305): 507–513. PMID: 11853816 DOI: 10.1016/S0140-6736(02)07681-X
    Pandian J.D., Thomas S.V., Santoshkumar B., Radhakrishnan K., Sarma P.S., Joseph S., Kesavadas C. Epilepsia partialis continua-a clinical and electroencephalography study. Seizure. 2002; 11 (7): 437–441.
    Varatharaj A., Nicoll James A.R., Pelosi E., Pinto A.A. Corticosteroid-responsive focal granulomatous herpes simplex type-1 encephalitis in adults. Practical Neurology. 2017; 17 (2): 140–144. PMID: 28153849 DOI: 10.1136/practneurol-2016-001474
    Sániová B., — Drobný M., Lehotský J., Šulaj M., Schudichová J: Biochemical and clinical improvement of cytotoxic state by amantadine sulphate In: Cellular and Molecular Neurobiology. 2006; 26 (7–8): 1473–1480. PMID: 16710757 DOI: 10.1007/s10571-006-9033-0
    Saniova B., Drobny M., Kneslova L., Minarik M. The outcome of patients with severe head injuries treated with amantadine sulphate. J Neural Transm. 2004; 111 (4): 511–514. PMID: 15057520 DOI: 10.1007/s00702-004-0112-4
    Wang Y., Qin Z.H. Molecular and cellular mechanisms of excitotoxic neuronal death. Apoptosis. 2010; 15: 1382–1402. DOI: 10.1007/s10495-010-0481-0
    Bien C.G., Bauer J., Deckwerth T.L., Wiendl H., Deckert M., Wiestler O.D., Schramm J., Elger C.E., Lassmann H. Destruction of neurons by cytotoxic T cells: a new pathogenic mechanism in Rasmussen’s encephalitis. Ann Neurol. 2002; 51 (3): 11–18. DOI: 10.1002/ana.10100
    O’Rourke D.J., Bergin A., Rotenberg A., Peters J., Gorman M., Poduri A., Cryan J., Lidov H., Madsen J., Harini C. Rasmussen’s encephalitis presenting as focal cortical dysplasia. Epilepsy Behav Case Rep 2014; 2, 86–89. PMID: 25667877 PMCID: PMC4307873 DOI: 10.1016/j.ebcr.2014.01.009
    Frigeri T., Hemb M., Paglioli E., Hoefel J.R., Silva V., Vinters H., Palmini A. Bilateral Rasmussen’s encephalitis associated with type II focal cortical dysplasia: dormant ‘second’ epileptogenic zone in contralateral disease. Epilepsy Behav Case Rep. 2013; 1: 66–68. PMID: 21216675 DOI: 10.1016/j.yebeh.2010.12.004
    Prayson R.A. Dual pathology in Rasmussen’s encephalitis: a report of coexistent focal cortical dysplasia and review of the literature. Case Rep Pathol. 2012; 2012: 1–4. PMID: 23056977 PMCID: PMC3465884 DOI: 10.1155/2012/569170
    Palmer C.A., Geyer J.D., Keating J.M., Gilliam F., Kuzniecky R.I., Morawetz R.B., Bebin E.M. Rasmussen’s encephalitis with concomitant cortical dysplasia: the role of GluR3. Epilepsia. 1999; 40: 242–247. PMID: 9952274 DOI: 10.1111/j.1528-1157.1999.tb02082.x
    Buzsáki G., Wang X. J. Mechanisms of Gamma Oscillations. Annu. Rev. Neurosci. 2012; 35: 203–225. PMID: 22443509 PMCID: PMC4049541 DOI: 10.1146/annurev-neuro-062111-150444
    Mukamel E. A., Pirondini Elvira., Babadi B.W., Kin F. K., Pierce E. T. P., Harrell P.G., Walsh J. L., Salazar-Gomez A. F., Cash S. S., Eskandar E. N., Weiner V. S., Brown E. N., Purdon. P.L. A Transition in Brain State during Propofol-Induced Unconsciousness. Journal of Neuroscience. 2014, 34 (3) 839–845. DOI: 10.1523/JNEUROSCI.5813-12.2014
    Cannon J., McCarthy M.M., Lee S., Lee J., Börgers Ch., Whittington M., Kopell N. Review Neurosystems; brain rhythms and cognitive processing. Eur J Neurosci. 2014; 39 (5): 705–719. PMID: 24329933 PMCID: PMC4916881 DOI: 10.1111/ejn.12453
    Fischer M., Drobny M., Saniova B., Bakosova E., Hamzik J., Schnierer M.,Osinova D. Electrical changes in deeper cortical structures during balanced general anesthesia with the aim on inhalation anesthetics effects. Acta Medica Martiniana. 2015; 15 (3): 21–29. DOI: 10.1515/acm-2015-0014
    Press C., Wallace A., Chapman K.E. The Janus-faced nature of Rasmussen’s encephalitis. Semin Pediatr Neurol. 2014; 21, 129–136. PMID: 25149947 DOI: 10.1016/j.spen.2014.04.018
    Castellano J.F., Meyer J.A., Lado F.A. A Case Series of Adult-Onset Rasmussen’s Encephalitis: Diagnostic and Therapeutic Challenges, Front Neurol. 2017; 8, 564. PMID: 29118737 PMCID: PMC5660978 DOI: 10.3389/fneur.2017.00564
    Bien C.G., Widman G., Urbach H., Sassen R., Kuczaty S., Wiestler O.D., Schramm J., Elger C.E. The natural history of Rasmussen’s encephalitis. Brain. 2002; 125 (8): 1751–1759. DOI: 10.1093/brain/awf176
    Eggers C., Burghaus L., Fink G.R., Dohmen C. Epilepsia partialis continua responsive to intravenous levetiracetam. Seizure. 2009; 18 (10): 716–718. PMID: 19836263 DOI: 10.1016/j.seizure.2009.09.005
    Pardo C.A., Vining E.P., Guo L., Skolasky R.L., Carson B.S., Freeman J.M. The pathology of Rasmussen syndrome: stages of cortical involvement and neuropathological studies in 45 hemispherectomies. Epilepsia. 2004; 45 (5): 516–526. DOI: 10.1111/j.0013-9580.2004.33103.x
    Bien C.G., Granata T., Antozzi C., Cross J.H., Dulac O., Kurthen M., Lassmann H., Mantegazza R., Villemure J.-G., Spreafico R., Elger C.E. Pathogenesis, diagnosis and treatment of Rasmussen encephalitis: a European consensus statement. Brain. 2005; 128 (3): 454-471. PMID: 15689357
    Takei H., Wilfong A., Malphrus A., Yoshor D., Hunter J.V., Armstrong D.L., Bhattacharjee M.B. Dual pathology in Rasmussen’s encephalitis: a study of seven cases and review of the literature. Neuropathology. 2009; 30: 381–391. PMID: 20051019 DOI: 10.1111/j.1440-1789.2009.01079.x
    Cheong J.Y., Wong C., Bleasel A., Varikatt W., Ng T., Dexter M.A. Late onset Rasmussen’s encephalitis with triple pathology. J Clin Neurosci. 2009; 16: 1677–1681. PMID: 19800797 DOI: 10.1016/j.jocn.2009.02.042
    Yacubian E.M., Rosemberg S., Marie S.K., Valério R.M., Jorge C.L., Cukiert A. Double pathology in Rasmussen’s encephalitis: etiologic considerations. Epilepsia. 1996; 37 (5): 495–500. PMID: 8617180 DOI: 10.1111/j.1528-1157.1996.tb00597.x
    Robitaille Y. Neuropathologic aspects of chronic encephalitis. In: Andermann F., editor. Chronic encephalitis and epilepsy Rasmussen’s syndrome. Boston: Butterworth-Heinemann; 1991: 79–110.
    Varadkar S., Bien C.G., Kruse C.A., Jensen F.E., Pardo C.A., Vincent A., Mathern G.W., Cross J.H. Rasmussen’s encephalitis: clinical features, pathobiology, and treatment advances. Lancet Neurol. 2014; 13 (2): 195–205. DOI: 10.1016/S1474-4422(13)70260-6
    Eggers C., Burghaus L., Fink G.R., Dohmen Ch. Epilepsia partialis continua responsive to intravenous levetiracetam. Seizure. 2009; 18 (10): 716–718. PMID: 19836263 DOI: 10.1016/j.seizure.2009.09.005